The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellerbroek, P. M.
Right arrow Articles by Coenjaerts, F. E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellerbroek, P. M.
Right arrow Articles by Coenjaerts, F. E. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2004, 173: 7513-7520.
Copyright © 2004 by The American Association of Immunologists

O-Acetylation of Cryptococcal Capsular Glucuronoxylomannan Is Essential for Interference with Neutrophil Migration1

Pauline M. Ellerbroek2,*,{dagger}, Dirk J. Lefeber2,*,{dagger}, Richard van Veghel{ddagger}, Jelle Scharringa*,{dagger}, Ellen Brouwer*,{dagger}, Gerrit J. Gerwig§, Guilhem Janbon, Andy I. M. Hoepelman*,{dagger} and Frank E. J. Coenjaerts3,*,{dagger}

* Department of Infectious Diseases and {dagger} Eijkman Winkler Institute for Microbiology, Division of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands; {ddagger} Department of Pharmacology, Erasmus University, Rotterdam, The Netherlands; § Department of Bio-Organic Chemistry, Section of Glycoscience and Biocatalysis, Bijvoet Center, Utrecht University, Utrecht, The Netherlands; and Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France

The capsular polysaccharide glucuronoxylomannan (GXM) of Cryptococcus neoformans has been shown to interfere with neutrophil migration. Although several receptors have been implied to mediate this process, the structural perspectives are unknown. Here, we assess the contribution of 6-O-acetylation and xylose substitution of the (1->3)-{alpha}-D-mannan backbone of GXM, the variable structural features of GXM, to the interference with neutrophil migration. We compare chemically deacetylated GXM and acetyl- or xylose-deficient GXM from genetically modified strains with wild-type GXM in their ability to inhibit the different phases of neutrophil migration. Additionally, we verify the effects of de-O-acetylation on neutrophil migration in vivo. De-O-acetylation caused a dramatic reduction of the inhibitory capacity of GXM in the in vitro assays for neutrophil chemokinesis, rolling on E-selectin and firm adhesion to endothelium. Genetic removal of xylose only marginally reduced the ability of GXM to reduce firm adhesion. In vivo, chemical deacetylation of GXM significantly reduced its ability to interfere with neutrophil recruitment in a model of myocardial ischemia (65% reduction vs a nonsignificant reduction in tissue myeloperoxidase, respectively). Our findings indicate that 6-O-acetylated mannose of GXM is a crucial motive for the inhibition of neutrophil recruitment.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
P.-Y. Cheng, A. Sham, and J. W. Kronstad
Cryptococcus gattii Isolates from the British Columbia Cryptococcosis Outbreak Induce Less Protective Inflammation in a Murine Model of Infection than Cryptococcus neoformans
Infect. Immun., October 1, 2009; 77(10): 4284 - 4294.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
J. Grijpstra, G. J. Gerwig, H. Wosten, J. P. Kamerling, and H. de Cock
Production of Extracellular Polysaccharides by CAP Mutants of Cryptococcus neoformans
Eukaryot. Cell, August 1, 2009; 8(8): 1165 - 1173.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
G. Rajam, G. M. Carlone, and S. Romero-Steiner
Functional Antibodies to the O-Acetylated Pneumococcal Serotype 15B Capsular Polysaccharide Have Low Cross-Reactivities with Serotype 15C
Clin. Vaccine Immunol., September 1, 2007; 14(9): 1223 - 1227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. McFadden, M. De Jesus, and A. Casadevall
The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction
J. Biol. Chem., January 27, 2006; 281(4): 1868 - 1875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.